New research suggests the new drug for ophthalmologists could be cheaper than generic drug

The pharmaceutical industry is pushing a new drug to treat the rare eye condition keratoconus.

The company is launching a study that suggests the drug could be a cheaper alternative to generic drugs.

But the study comes at a time when a number of insurers are pushing to cut back on the drug’s use.

Read more from The Globe and Mail…